On 12 Nov 2026 CVS Health closed at $89.79, +16.6% this year; market cap $115.92bn, P/E 10.5.
Health Care · Health Care Services · NYSE · United States
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
| Market cap | $115.92bn |
| P/E (trailing) | 10.5 |
| EPS (TTM) | $8.56 |
| Beta | 0.58 |
| Dividend | $2.66 |
| Dividend yield | 2.96% |
| Ex-dividend date | 22 Oct 2026 |
| Latest report | 4 Nov 2026 |
| Next earnings | 3 Feb 2027 |
| YTD | +16.6% |
| 1Y | +15.3% |
| 3Y | +14.1% |
| 5Y | +2.5% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $402.07bn | $1.77bn | $7.81bn |
| 2024 | $372.81bn | $4.61bn | $6.33bn |
| 2023 | $357.78bn | $8.34bn | $10.39bn |
| 2022 | $322.47bn | $4.31bn | $13.45bn |
| 2021 | $292.11bn | $8.00bn | $15.74bn |
We publish no single base value for CVS Health. Our valuation methods put it between $67.89 and $261.28 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.